Text

Gluten-Free Diet

---

For decades, gluten-free dieting (GFD) has been accepted as the only therapeutic approach to
coeliac disease (CD) and, more recently, for non-coeliac gluten sensitivity (NCGS), a term to refer to
the so-called gluten-related disorders (GRD) [1].
GFD has become popular among the general population for its supposed beneficial effects on
human health [2]. GFD is also the most frequently suggested dietary regimen in irritable bowel
syndrome (IBS) [3].
In fact, there are several concerns and misconceptions regarding GFD, which deserve special
attention. For such a reason, this Special Issue on “Gluten-Free Diet” comprises 23 peer-reviewed
papers, reporting on the most recent evidence and topics about GFD. In particular, the impact of GFD
on human health and quality of life; the emerging evidence of its beneficial effects in IBS; and the
difficult problems of compliance, costs, and availability of GF food are discussed.
Several sources of evidence support the notion that, despite its remarkable effectiveness in
remitting the vast majority of GRD symptoms, GFD comes with both a social and financial burden.
Gluten-free foods are still less available and more expensive than their gluten-containing versions [4],
thus causing patients social and psychological consequences in securing good quality of life and
compliance with the advised dietary regimen.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

616 GLU

Publisher

Basel : MDPI - Multidisciplinary Digital Publishing Institute., 2019

Collation

-

Language

English

ISBN/ISSN

978-3-03897-737-7

Classification

616

Content Type

text

Media Type

computer

Carrier Type

online resource

Edition

-

Subject(s)

Internal medicine

Specific Detail Info

-

Statement of Responsibility

Penyunting, Luca Elli

Other Information

Cataloger

maya

Source

-

Validator

maya

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment